145 related articles for article (PubMed ID: 6112153)
1. Solubilization of neuroleptic/dopamine receptors of human brain striatum.
Davis A; Madras B; Seeman P
Eur J Pharmacol; 1981 Mar; 70(3):321-9. PubMed ID: 6112153
[TBL] [Abstract][Full Text] [Related]
2. Solubilization and characterization of striatal dopamine receptors.
Lew JY; Goldstein M
J Neurochem; 1984 May; 42(5):1298-305. PubMed ID: 6707634
[TBL] [Abstract][Full Text] [Related]
3. Properties of rat striatal D-2 dopamine receptors solubilized with the zwitterionic detergent CHAPS.
Kilpatrick GJ; Jenner P; Marsden CD
J Pharm Pharmacol; 1985 May; 37(5):320-8. PubMed ID: 2862240
[TBL] [Abstract][Full Text] [Related]
4. Solubilization of D2 dopamine receptor coupled to guanine nucleotide regulatory protein from bovine striatum.
Kuno T; Saijoh K; Tanaka C
J Neurochem; 1983 Sep; 41(3):841-7. PubMed ID: 6308173
[TBL] [Abstract][Full Text] [Related]
5. Investigation of rat striatal dopamine D-1 receptors solubilized by digitonin with a precipitation method.
Zhang X; Segawa T
Eur J Pharmacol; 1989 Aug; 166(3):401-10. PubMed ID: 2680521
[TBL] [Abstract][Full Text] [Related]
6. Solubilisation of high-affinity dopamine receptors.
Gorissen H; Laduron P
Nature; 1979 May; 279(5708):72-4. PubMed ID: 450076
[No Abstract] [Full Text] [Related]
7. Comparison of soluble dopamine D2-receptors from three species.
Madras BK; Davis A; Seeman P
Eur J Pharmacol; 1982 Mar; 78(4):431-8. PubMed ID: 7075677
[TBL] [Abstract][Full Text] [Related]
8. Dopamine agonist high-affinity state in solubilized D2 receptors in striatum, but not in anterior pituitary.
Dumbrille-Ross A; Seeman P
Biochem Pharmacol; 1987 Jul; 36(13):2095-9. PubMed ID: 2955789
[TBL] [Abstract][Full Text] [Related]
9. Preparation of an affinity chromatography matrix for the selective purification of the dopamine D2 receptor from bovine striatal membranes.
Clagett-Dame M; Schoenleber R; Chung C; McKelvy JF
Biochim Biophys Acta; 1989 Nov; 986(2):271-80. PubMed ID: 2531613
[TBL] [Abstract][Full Text] [Related]
10. Dopamine receptor of the porcine anterior pituitary gland. Solubilization and characterization.
Kilpatrick BF; Caron MG
Biochem Pharmacol; 1984 Jun; 33(12):1981-8. PubMed ID: 6547344
[TBL] [Abstract][Full Text] [Related]
11. Comparison of [3H]YM-09151-2 with [3H]spiperone and [3H]raclopride for dopamine d-2 receptor binding to rat striatum.
Terai M; Hidaka K; Nakamura Y
Eur J Pharmacol; 1989 Dec; 173(2-3):177-82. PubMed ID: 2576228
[TBL] [Abstract][Full Text] [Related]
12. Similarities and dissimilarities between dopamine and neuroleptic receptors: further evidence for type 1 and type 2 dopamine receptors in the CNS.
Spano PF; Memo M; Govoni S; Trabucchi M
Adv Biochem Psychopharmacol; 1980; 24():113-21. PubMed ID: 6105769
[No Abstract] [Full Text] [Related]
13. Chronic continuous administration of neuroleptic drugs alters cerebral dopamine receptors and increases spontaneous dopaminergic action in the striatum.
Murugaiah K; Theodorou A; Mann S; Clow A; Jenner P; Marsden CD
Nature; 1982 Apr; 296(5857):570-2. PubMed ID: 6122161
[No Abstract] [Full Text] [Related]
14. Ascorbate injury and EDTA (or manganese) protection of D2-dopamine receptors.
Chan B; Seeman P; Davis A; Madras BK
Eur J Pharmacol; 1982 Jun; 81(1):111-6. PubMed ID: 6126367
[TBL] [Abstract][Full Text] [Related]
15. Drug potencies on partially purified brain D2 dopamine receptors.
Madras BK; Seeman P
J Neurochem; 1985 Mar; 44(3):856-61. PubMed ID: 2579201
[TBL] [Abstract][Full Text] [Related]
16. Abnormal neuroleptic/dopamine receptors in schizophrenia.
Lee T; Seeman P
Adv Biochem Psychopharmacol; 1980; 21():435-42. PubMed ID: 6103653
[TBL] [Abstract][Full Text] [Related]
17. Solubilized receptors for [3H]dopamine (D3 binding sites) from canine brain.
Davis A; Madras BK; Seeman P
Biochem Pharmacol; 1982 Apr; 31(7):1183-7. PubMed ID: 7092913
[TBL] [Abstract][Full Text] [Related]
18. Effect of timiperone on 3H-spiroperidol binding to rat striatal dopamine receptors.
Tachizawa H; Sudo K; Sano M
Eur J Pharmacol; 1979 Nov; 59(3-4):245-51. PubMed ID: 43256
[TBL] [Abstract][Full Text] [Related]
19. Solubilization and characterization of 3H-spiroperidol binding sites of calf caudate.
Lerner MH; Rosengarten H; Friedhoff AJ
Life Sci; 1981 Dec; 29(23):2367-74. PubMed ID: 6172690
[No Abstract] [Full Text] [Related]
20. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
Hancock AA; Marsh CL
Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
